A service of StreetInsider.com
Welcome

Most Popular

AAPL 222.25
C 3.90
GOOG 560.00
BAC 16.82
RIMM 73.06

Recently Added

WWIN 6.46
CCLTF 9.20
KCAP 5.51
NWM 0.01
CNYD 13.05

Gaining Speed

CCLTF 9.20
KCAP 5.51
CNYD 13.05
FGEXF 0.35
HYII 0.00
1.56 -0.04 (-2.48%) PARD

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:1.56 Change:-0.04 (-2.48%) Prev Close:1.60 Open: 1.61 Days Range:1.56 – 1.62 52 Week Range: 1.50 - 9.14 Volume:1536268 P/E: N/A
EPS:-1.31





Recent Blog Posts

Blog Posts on 02/08/10 at 4:14am
GlaxoSmithKline, Poniard, Protalix Provide Biotech's Latest Mishaps
Blog Posts on 01/25/10 at 11:45am
Analyst Upgrades, Downgrades and Initiations: GD, ICE, IGT, SAP, STI, TMH, TSS ...
Blog Posts on 01/22/10 at 5:29pm
Poniard Pharmaceuticals: A Rebound Is Overdue
Blog Posts on 01/11/10 at 4:04am
Poniard Pharmaceuticals: Oversold, Undervalued, Poised for Short Squeeze
Blog Posts on 12/15/09 at 4:08pm
Tuesday Options Recap: Put-Call Ratio Leaders
Blog Posts on 12/07/09 at 10:06am
Options Trader: Monday Market Movement
Blog Posts on 11/25/09 at 4:05am
Azimuth Opportunity Bets on Poniard's Survival
Blog Posts on 11/23/09 at 4:11am
Weak Weekly Market Wrap-Up: Primed for a Correction
Blog Posts on 11/18/09 at 12:58pm
Poniard Pharmaceuticals' Gamble Doesn't Pay Off
Blog Posts on 11/18/09 at 11:45am
Analyst upgrades, downgrades and initiations: FIS, LMNX, RIMM, SII, TGT, TSYS ...
Blog Posts on 11/17/09 at 4:01pm
Tuesday Options Recap
Blog Posts on 11/17/09 at 5:02am
BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI
Blog Posts on 11/16/09 at 4:16pm
Monday Options Recap
Blog Posts on 10/23/09 at 10:09am
Options Trader Friday Outlook: Churn Baby Churn
Blog Posts on 10/19/09 at 3:58pm
Monday Options Recap
Blog Posts on 09/20/09 at 4:50pm
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Blog Posts on 09/16/09 at 4:03pm
Wednesday's Options Recap
Blog Posts on 09/11/09 at 9:38am
Options Trader Friday Outlook: Up, Up and Away
Blog Posts on 09/11/09 at 5:49am
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Blog Posts on 08/23/09 at 9:43am
Biotech Dealmaking Takes a Summer Breather
Blog Posts on 07/31/09 at 3:59pm
Friday Options Recap
Blog Posts on 07/28/09 at 11:30am
Analyst upgrades, downgrades and initiations: AMGN, CS, DB, LEN, MET, SNI, X ...
Blog Posts on 07/27/09 at 4:14am
FDA Calendar: 2H09 Binary Event Trades
Blog Posts on 07/01/09 at 7:53am
Big Lineup of Healthcare Stocks Crack the Russell 3000 Index
Blog Posts on 06/19/09 at 8:36am
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
Blog Posts on 05/14/09 at 6:33am
Pending Clinical Trial Results: Ten Extreme Trades
Blog Posts on 04/13/09 at 4:21am
Tracking Cancer Diagnostic and Therapeutic Stocks
Blog Posts on 03/18/09 at 11:10am
Analyst upgrades, downgrades and initiations: CBRL, INTC, LLY, RDS.A, NTDOY ...
Blog Posts on 11/10/08 at 5:48am
Rigel Pharmaceuticals: Biotech Crisis or Opportunity?
Blog Posts on 05/30/08 at 2:42am
Poniard Pharmaceuticals: Platinum Rediscovered (Part I)